Commentary on: Corponi F., Fabbri C, Bitter, I. Montgomery, S., Vieta, E., Kaspar, S., Pallanti S., Serretti A. Novel antipsychotics specificity profile: A clinically oriented review of lurasidone, brexpiprazole, cariprazine and lumateperone-Reference-Cited by-同舟云学术

Commentary on: Corponi F., Fabbri C, Bitter, I. Montgomery, S., Vieta, E., Kaspar, S., Pallanti S., Serretti A. Novel antipsychotics specificity profile: A clinically oriented review of lurasidone, brexpiprazole, cariprazine and lumateperone

Published:2019-09 Issue:9 Volume:29 Page:1061-1062
ISSN:0924-977X
Container-title:European Neuropsychopharmacology
language:en
Short-container-title:European Neuropsychopharmacology

Author:

Davis John M.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,Neurology (clinical),Neurology,Pharmacology

Reference10 articles.

1. Pharmacological treatment of adult bipolar disorder;Baldessarini;Mol. Psychiatry,2019

2. Lurasidone dose response in bipolar depression: a population dose-response analysis;Chapel;Clin. Ther.,2016

3. Efficacy and safety of adjunctive cariprazine in inadequate responders to antidepressants: a randomized, double-blind, placebo-controlled study in adult patients with major depressive disorder;Durgam;J. Clin. Psychiatry,2016

4. Cariprazine augmentation to antidepressant therapy in major depressive disorder: results of a randomized, double-blind, placebo-controlled trial;Earley;Psychopharmacol Bull.,2018

5. Efficacy of adjunctive low-dose cariprazine in major depressive disorder: a randomized, double-blind, placebo-controlled trial;Fava;Int. Clin. Psychopharmacol,2018

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of lumateperone in the treatment of schizophrenia;Therapeutic Advances in Psychopharmacology;2021-01

2. Evidence on the New Drug Lumateperone (ITI-007) for Psychiatric and Neurological Disorders;CNS & Neurological Disorders - Drug Targets;2020-10-13